Fangchinoline 防己诺林碱,99.92%
产品编号:Bellancom-N1372A| CAS NO:436-77-1| 分子式:C37H40N2O6| 分子量:608.72
Fangchinoline 从 Stephaniatetrandra 中分离出来的,具有广泛的生物学活性,例如增强免疫力,消炎杀菌和抗动脉粥样硬化。Fangchinoline 是新型 HIV-1 抑制剂,通过损害 gp160 蛋白水解过程来抑制 HIV-1 复制。Fangchinoline 靶向 Focal adhesion kinase (FAK) 并抑制肿瘤细胞中 FAK 介导的的信号传导途径。Fangchinoline 诱导膀胱癌的凋亡 (apoptosis) 和适应性自噬 (autophagy)。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Fangchinoline 防己诺林碱
产品介绍 | Fangchinoline 从 Stephania tetrandra 中分离出来的,具有广泛的生物学活性,例如增强免疫力,消炎杀菌和抗动脉粥样硬化。Fangchinoline 是新型 HIV-1 抑制剂,通过损害 gp160 蛋白水解过程来抑制 HIV-1 复制。Fangchinoline 靶向 Focal adhesion kinase (FAK) 并抑制肿瘤细胞中 FAK 介导的的信号传导途径。Fangchinoline 诱导膀胱癌的凋亡 (apoptosis) 和适应性自噬 (autophagy)。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Fangchinoline is isolated from Stephania tetrandra with extensive biological activities, such as enhancing immunity, anti-inflammatory sterilization and anti-atherosclerosis. Fangchinoline, a novel HIV-1 inhibitor, inhibits HIV-1 replication by impairing gp160 proteolytic processing. Fangchinoline targets Focal adhesion kinase (FAK) and suppresses FAK-mediated signaling pathway in tumor cells which highly expressed FAK. Fangchinoline induces apoptosis and adaptive autophagy in bladder cancer. | ||||||||||||||||
体外研究 |
Fangchinoline (2.5-40 µM; 24-96 hours) inhibits both T24 and 5637 cells in dose-dependent manner, the IC50 values of Fangchinoline in T24 cells are 19.0 µM (24 h), 12.0 µM (48 h) and 7.57 µM (72 h), and 11.9 µM (24 h), 9.92 µM (48 h) and 7.13 µM (72 h) in 5637 cells. Fangchinoline (5 µM; 24 hours) induces a significant increase in the LC3-II/LC3-I ratio and a decrease in p62 in both T24 and 5637 cells, and causes a significant increase in the cleavage of caspase-3. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay
Western Blot Analysis
|
||||||||||||||||
分子量 |
608.72 |
||||||||||||||||
性状 |
Solid |
||||||||||||||||
Formula |
C37H40N2O6 |
||||||||||||||||
CAS 号 |
436-77-1 |
||||||||||||||||
中文名称 |
防己诺林碱 |
||||||||||||||||
结构分类 |
|
||||||||||||||||
初始来源 |
| ||||||||||||||||
体内研究 | |||||||||||||||||
体内研究 | |||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 50 mg/mL (82.14 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
参考文献 |
|
~36%
详细
|
文献:Pachaly; Praest Archiv der Pharmazie, 1982 , vol. 315, # 7 p. 589 - 597 |
~36%
详细
|
文献:Pachaly; Praest Archiv der Pharmazie, 1982 , vol. 315, # 7 p. 589 - 597 |
~32% ![]() 436-77-1 |
文献:Kunitomo, Jun-ichi; Oshikata, Megumi; Akasu, Michinori; Ishii, Hisashi Heterocycles, 1992 , vol. 34, # 5 p. 937 - 942 |
~35%
详细
|
文献:Pachaly; Praest Archiv der Pharmazie, 1982 , vol. 315, # 7 p. 589 - 597 |
上游产品 1 | |
---|---|
下游产品 2 | |

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存